BioCentury
ARTICLE | Company News

Cephalon, Mepha deal

April 19, 2010 7:00 AM UTC

Cephalon completed its previously announced acquisition of generics company Mepha for CHF662.4 million ($623.4 million) in cash. Mepha will become a wholly owned subsidiary of Cephalon (see BioCentury...